EUCTR2004-002715-92-GB进行中（未招募）1 期
A randomised, control, assessor blinded, dose escalating study to compare high dose rocuronium and suxamethonium for use in rapid sequence inductionof anaesthesia - Rocuronium or suxamethonium for rapid sequence induction
Royal Group Hospitals0 个研究点目标入组 75 人开始时间: 2005年7月7日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 75
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •ASA class I-III
- •aged 18-65
- •scheduled to undergo elective surgery
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Taking medication known to interact with neuromuscular blocking drugs
- •Known or suspected anaphylaxis to any of the study medications
- •Suspected difficult intubation
研究者
相似试验
进行中（未招募）
不适用
Gaviscon Exploratory pH Monitoring StudyEUCTR2014-003158-15-NLReckitt Benckiser Healthcare (UK) Limited
进行中（未招募）
1 期
A controlled, randomized, assessor blinded, open-label study to investigate whether initiation of everolimus will reduce the incidence of developing a new Squamous Cell Carcinoma (SCC) and other malignancies in Renal Transplanted Recipients with at least one SCC during the last 2 yearsSquamous cell carcinoma (SCC) and other malignancies in renal transplanted recipientsMedDRA version: 17.0Level: PTClassification code 10041823Term: Squamous cell carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2012-005481-35-DKppsala University Hospital220
招募中
4 期
A clinical trial to assess the comparative efficacy andsafety of a silver dressing against standard cotton dressing in the rate of Wound Healing after and operative procesureCTRI/2017/03/008090Clinfound Clinical Research Services PvtLtd100
已完成
不适用
ANTICS: Antibiotic implant in cardiac surgeryTopic: CardiovascularSubtopic: Cardiovascular (all Subtopics)Disease: CardiovascularInjury, Occupational Diseases, PoisoningSternal wound infectionISRCTN57443262Plymouth Hospitals NHS Trust (UK)200
进行中（未招募）
不适用
An randomized, controlled, investigator-blinded, prospective, mono-centre study to evaluate the efficacy of fosfomycin versus meropenem in patients with complicated urinary tract infections - urosepsis/fosfo vs. meropenemThis study will primarily address the question of the efficacy of intravenous fosfomycin 4 g b.i.d. in the therapy of patients presenting with complicated urinary tract infection. These data will be compared to meropenem administered intravenously at a dose of 2 g b.i.d.MedDRA version: 9.1Level: LLTClassification code 10046571Term: Urinary tract infectionEUCTR2007-005112-37-ATMedizinische Universität Wien, Abteilung für Interne Medizin I240